AI Akciğer Nodülü Tespiti

A lung nodule is a rounded spot in the lung up to about 3 cm across. Anything larger is usually called a mass. Nodules are very common, and most are old scars, infections or benign growths. On CT they are described as solid, part-solid or ground-glass, and each type carries a different risk. Screening is where AI has drawn the most attention. The US National Lung Screening Trial, reported in 2011, found that low-dose CT reduced lung cancer deaths by about 20 percent compared with chest X-ray. The European NELSON trial later confirmed a benefit. In 2021 the US Preventive Services Task Force recommended annual screening for adults aged 50 to 80 with at least a 20 pack-year smoking history who still smoke or quit within the past 15 years. The American College of Radiology's Lung-RADS system standardizes how screening scans are reported and followed up. Nodules found by chance on scans done for other reasons are usually managed with Fleischner Society guidelines. AI does three separate jobs. Detection finds candidate nodules. Measurement segments each nodule to get its size and volume. Characterization estimates the risk of cancer. A 2019 Google study in Nature Medicine trained a deep learning model on NLST scans. In retrospective tests without a prior scan to compare, it matched or beat radiologists at predicting cancer. Sybil, developed at MIT and Massachusetts General Hospital, estimates a person's risk of lung cancer over the following years from a single low-dose CT, even when no suspicious nodule is visible. False positives are the central tradeoff. In NLST, roughly a quarter of screens were positive, and the vast majority of those were not cancer. A more sensitive detector marks more spots, which adds reading time, follow-up scans, anxiety and occasionally invasive procedures. A common misconception is that AI diagnoses lung cancer. It flags and estimates risk, and only tissue sampling confirms cancer.